VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 230 filers reported holding VERACYTE INC in Q2 2023. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284 | -66.9% | 12,384 | -62.7% | 0.01% | -61.8% |
| Q2 2023 | $859 | -5.5% | 33,170 | -24.9% | 0.03% | -5.6% |
| Q1 2023 | $909 | -14.6% | 44,176 | 0.0% | 0.04% | -12.2% |
| Q4 2022 | $1,064 | -99.9% | 44,176 | 0.0% | 0.04% | -25.5% |
| Q3 2022 | $736,000 | -16.6% | 44,176 | 0.0% | 0.06% | +41.0% |
| Q2 2022 | $882,000 | -30.7% | 44,176 | 0.0% | 0.04% | -11.4% |
| Q1 2022 | $1,272,000 | -50.3% | 44,176 | -22.0% | 0.04% | -47.0% |
| Q3 2021 | $2,560,000 | +9.6% | 56,623 | 0.0% | 0.08% | +5.1% |
| Q2 2021 | $2,336,000 | -58.8% | 56,623 | -50.5% | 0.08% | -64.1% |
| Q1 2021 | $5,671,000 | -2.9% | 114,500 | 0.0% | 0.22% | -12.7% |
| Q4 2020 | $5,838,000 | +55.6% | 114,500 | 0.0% | 0.25% | +17.2% |
| Q3 2020 | $3,753,000 | +39.4% | 114,500 | +10.2% | 0.22% | +28.0% |
| Q2 2020 | $2,693,000 | – | 103,900 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |